Butyrate Ameliorates Graves' Orbitopathy Through Regulating Orbital Fibroblast Phenotypes and Gut Microbiota. [PDF]
Ouyang P +7 more
europepmc +1 more source
Predictive modeling of graves' orbitopathy activity based on meibomian glands analysis using in vivo confocal microscopy. [PDF]
Su Z +6 more
europepmc +1 more source
PDK2-enhanced glycolysis aggravates fibrosis via IL11 signaling pathway in Graves' orbitopathy. [PDF]
Peng Z +12 more
europepmc +1 more source
Association of Lower Alanine Transaminase (ALT) and Aspartate Aminotransferase (AST) Levels With Eyelid Edema in Graves' Orbitopathy: A Retrospective Cross-Sectional Study. [PDF]
Xiang Y +5 more
europepmc +1 more source
Canonical and Truncated Transglutaminase-2 Drive TGF-β1 Autocrine Loop to Induce Fibrosis in Graves' Orbitopathy. [PDF]
Bao X +7 more
europepmc +1 more source
Therapeutic role of histone deacetylase inhibition in an in vitro model of Graves' orbitopathy. [PDF]
Byeon HJ +4 more
europepmc +1 more source
Strabismus surgery in topical anaesthesia with intraoperative suture adjustment in Graves' orbitopathy. [PDF]
Haugen OH +3 more
europepmc +1 more source
Concomitant Exacerbation of Graves Orbitopathy and Double-Seronegative Myasthenia Gravis after SARS-CoV-2 Infection. [PDF]
Nakano Y +5 more
europepmc +1 more source
Related searches:
Graves' orbitopathy (GO) is an autoimmune orbital disease which is mostly associated with Graves' disease and requires good interdisciplinary cooperation. To minimize irreversible damages a stage-adapted anti-inflammatory therapy is of great importance.Discussion of the latest results of new findings of the pathogenesis, randomized controlled trials on
Eckstein, Anja +3 more
openaire +2 more sources

